FDA Approves LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Hospira, Inc.

# FDA Approves Hospira's Lidocaine Hydrochloride and Epinephrine for Epidural Use Hospira, Inc. has received FDA approval for its lidocaine hydrochloride and epinephrine formulation for epidural administration, expanding the company's anesthetic portfolio and positioning it to capture market share in the regional anesthesia segment used for pain management and surgical procedures. The approval strengthens Hospira's competitive standing in the injectable pharmaceutical market, particularly for hospital and surgical center customers seeking reliable local anesthetic solutions.